Within the SHH subgroup, lower EPLIN expression was significantly associated with poorer overall survival (n = 172, p = 0.018, Supplementary Fig. 7D), suggesting a potential subtype-specific role of EPLIN in medulloblastoma progression. The gene discussed is LIMA1; the disease is medulloblastoma.